Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,403 | 13,297 | 12,383 | 13,985 | 4,980 |
| Receivables | N/A | 250 | N/A | N/A | N/A |
| TOTAL | $17,411 | $14,309 | $14,733 | $15,158 | $7,415 |
| Non-Current Assets | |||||
| PPE Net | 11 | 9 | 10 | 12 | 2 |
| Other Non-Current Assets | 868 | 944 | 1,020 | 1,096 | 389 |
| TOTAL | $879 | $953 | $1,030 | $1,108 | $391 |
| Total Assets | $18,290 | $15,262 | $15,763 | $16,266 | $7,806 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 411 | N/A | 88 | 352 | 611 |
| Accounts payable and accrued liabilities | 922 | 706 | 1,759 | 1,725 | 1,041 |
| Accrued Expenses | 889 | 500 | 1,060 | 1,335 | 1,110 |
| TOTAL | $2,335 | $1,315 | $3,012 | $3,513 | $2,860 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 155 | 200 | 272 | 323 | 735 |
| TOTAL | $155 | $200 | $272 | $323 | $735 |
| Total Liabilities | $2,490 | $1,515 | $3,284 | $3,836 | $3,595 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 457 | 447 | 300 | 103 | 29 |
| Common Shares | 69 | 46 | 30 | 771 | 220 |
| Retained earnings | -114,923 | -111,530 | -109,190 | -105,182 | -101,191 |
| Other shareholders' equity | 2 | 2 | 2 | 2 | 2 |
| TOTAL | $15,800 | $13,747 | $12,479 | $12,430 | $4,211 |
| Total Liabilities And Equity | $18,290 | $15,262 | $15,763 | $16,266 | $7,806 |